文献速递生殖医学

值得等待吗?第7天囊胚的整倍体率较低,但持续种植率与第5天和第6天囊胚相似

Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts.
PubMed 文献 · Hum Reprod · 2019-01-01

这项单中心回顾性队列研究分析了2017年1月至2018年9月接受ICSI和PGT-A筛查的患者,发现随着囊胚形成时间延长,整倍体率下降(第5天67.7%、第6天52.1%、第7天43.1%),但控制形态和内膜-胚胎不同步后,第7天整倍体囊胚的持续种植率与第5、6天相似(52.6% vs 68.9%和66.8%),差异未达统计学显著。

要点

  • 随着囊胚形成时间延长,整倍体率显著下降:第5天67.7%、第6天52.1%、第7天43.1%。
  • 第5天与第6天整倍体单胚胎移植的持续种植率相似(68.9% vs 66.8%,P=0.81)。
  • 第7天整倍体单胚胎移植的持续种植率为52.6%,与第5、6天相比差异未达统计学显著。

核心结论

  • 整倍体率随囊胚形成时间延长而增加非整倍体风险,但控制囊胚形态质量和内膜-胚胎不同步后,第7天整倍体胚胎的持续种植率与第5天和第6天整倍体囊胚相似。

研究设计与样本

  • 单中心回顾性队列研究,纳入2017年1月至2018年9月通过ICSI和PGT-A尝试妊娠的患者,评估2586例ICSI周期的胚胎倍性状态。
  • 分析按囊胚扩张日分的单整倍体冷冻 embryo 移植结局时纳入2130例,并调整母亲年龄和囊胚形态。

主要发现

  • 可用第5天囊胚整倍体率为67.7%(n=3508),第6天为52.1%(n=5560),第7天为43.1%(n=229);第5天 vs 第6天 OR 0.7(95%CI 0.64-0.76),P<0.001;第5天 vs 第7天 OR 0.56(95%CI 0.46-0.69),P<0.001;第6天 vs 第7天 OR 0.81(95%CI 0.67-0.99),P=0.036。
  • 按美国辅助生殖技术学会母亲年龄组分层后,随囊胚形成时间延长整倍体率下降仍可见。
  • 整倍体单胚胎移植后持续种植率:第5天68.9%(95%CI 66.0-71.6),第6天66.8%(95%CI 63.8-69.7),P=0.81;第7天52.6%(95%CI 35.8-69.0);第5天 vs 第7天 OR 0.67(95%CI 0.32-1.41),P=0.29;第6天 vs 第7天 OR 0.58(95%CI 0.28-1.2),P=0.14,均未达统计学显著。

临床怎么用

  • 作者认为,常规培养至第7天可能为原本在第6天终止培养便无可用胚胎的患者增加可移植胚胎池,尤其对年龄大于35岁、囊胚形成更慢因而更易取消周期的患者。
  • 作者认为,第7天发育为可用囊胚的胚胎可能仍在「囊胚形成窗口」内,依据是第7天整倍体单胚胎移植后总体持续种植率52.6%。

局限性

  • 主要局限性是第7天囊胚移植数量少,限制了统计效能。
  • 本研究的回顾性性质可能无法完全阐明培养、形态评估和选择第7天胚胎移植方面的潜在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does the reproductive potential of embryos change when blastocyst development takes longer than the traditionally accepted 5 days when accounting for aneuploidy and endometrial-embryo asynchrony? SUMMARY ANSWER: Aneuploidy increases with increasing duration of blastulation, but if blastocyst morphologic quality and endometrial-embryo asynchrony are controlled for, euploid Day 7 embryos have similar sustained implantation as compared to Days 5 and 6 euploid blastocysts. WHAT IS KNOWN ALREADY: The relative contributions of diminished embryo quality versus endometrial and embryo asynchrony to poor outcomes associated with embryos cultured past Day 6 are not clear. Asynchrony can be eliminated by embryo vitrification with transfer in a subsequent month after retrieval. STUDY DESIGN, SIZE, DURATION: Retrospective cohort study of patients from a single center attempting conception through ICSI and utilizing preimplantation genetic testing for aneuploidy screening (PGT-A) from January 2017 to September 2018. Cycles were excluded if they utilized surgical sperm or preimplantation genetic testing for monogenetic/single gene defects. ICSI cycle outcomes from 2586 patients were evaluated for ploidy status of embryos. PARTICIPANTS/MATERIALS, SETTING, METHODS: Only patients undergoing single, euploid frozen embryo transfer were included when analyzing cycle outcomes by day of blastocyst expansion of the transferred embryo (n = 2130). Ploidy rates by the day upon which an embryo was considered to be usable (denoted, 'usable blastulation day') were determined so as to assess the contribution of aneuploidy to slow embryo development. Outcomes of euploid frozen single embryo transfers (SET) of Day 7 embryos were evaluated to assess the reproductive potential associated with embryos that were slowly developing for reasons other than aneuploidy. Analyses were adjusted by maternal age and blastocyst morphology. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, 67.7% (n = 3508) of usable Day 5 blastocysts were euploid, 52.1% (n = 5560) of usable Day 6 blastocysts were euploid and 43.1% (n = 229) of usable Day 7 embryos were euploid (Day 5 versus Day 6: odds ratio (OR) 0.7 (95% CI, 0.64-0.76), P < 0.001; Day 5 versus Day 7: OR 0.56 (95% CI, 0.46-0.69), P < 0.001; Day 6 versus Day 7: OR 0.81 (95% CI, 0.67-0.99), P = 0.036). Stratified by Society for Assisted Reproductive Technology maternal age groups, a reduction in the prevalence of euploidy by increasing time to embryo blastulation was still seen. The sustained implantation rate (SIR) was similar after euploid SET of Days 5 and 6 embryos (overall, 68.9% (95% CI, 66.0-71.6) and 66.8% (95% CI, 63.8-69.7), respectively; P = 0.81). SIR after euploid Day 7 SET appeared slightly lower than that of Days 5 and 6 embryos (52.6% (95% CI, 35.8-69.0); (Day 5 versus Day 7: OR, 0.67 (95% CI, 0.32-1.41), P = 0.29; Day 6 versus Day 7: OR 0.58 (95% CI, 0.28-1.2), P = 0.14)) but did not achieve statistical significance. LIMITATIONS, REASONS FOR CAUTION: The primary limitation is the low number of Day 7 blastocyst transfers that limits statistical power. Additionally, the retrospective nature of this study may prevent full elucidation of potential biases with respect to culture, morphologic assessment and selection of Day 7 embryos for transfer. WIDER IMPLICATIONS OF THE FINDINGS: Routine culture through Day 7 may successfully increase the pool of transferrable embryos for patients who would otherwise have no usable embryos if culture terminated on Day 6. This is particularly true for older patients (i.e. greater than 35 years of age), whose embryos take longer to blastulate and, therefore, are more susceptible to cycle cancelation. Additionally, as evidenced by an adequate overall SIR of 52.6% after euploid SET of Day 7 blastocysts, embryos developing to a usable blastocyst on Day 7 are likely within the 'window of blastulation.' STUDY FUNDING/COMPETING INTEREST(S): None.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Tiegs AW, Sun L, Patounakis G, et al. Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts. Hum Reprod. 2019. PMID: 31402381. doi:10.1093/humrep/dez138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。